1. Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.
2. Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.
3. Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.
4. QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.
5. Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.
6. Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.
7. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
8. Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.
9. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
10. Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
11. Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.
12. Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.
13. Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
14. Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
15. Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.
16. Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, CA, USA.
17. Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
18. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.